Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | March 03, 2025 | March 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date March 03, 2025 · Filed March 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,259 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Sale · Disposed 2,236 · Balance 8,970 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2025-03-03 · Sale · Disposed 1,233 · Balance 7,737 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2025-03-03 · Sale · Disposed 478 · Balance 7,259 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectHeld by son | 167 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 167 |
| Common StockSEC Table I · non-derivative | IndirectHeld by daughter | 166 |
Reported balance
Holding disclosure · report date 2025-03-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 166 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.64 to $186.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.71 to $187.21. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2020 Filed Sep 11, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 24,808 | $117.03 | $2,903,280.24 |
DisclosureSEC source: 0001104659-20-104418 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,381 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.00 to $117.83. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 30,000 | $1.14 | $34,200.00 |
DisclosureSEC source: 0001104659-20-104418 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 47 additional shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on April 10, 2020. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-20-045588 · a4.xml · derivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,187 Underlying: Common Stock · 10,000 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 10,000 | $64.00 | $640,000.00 |
DisclosureSEC source: 0001104659-20-045588 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $1.14 | $11,400.00 |
DisclosureSEC source: 0001104659-20-045588 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 142 additional shares acquired under the Company's 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on March 9, 2020. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · derivative · entry 11 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,187 Underlying: Common Stock · 10,000 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option is fully vested and exercisable. F10 · derivative.expiration_date: This option grant was previously reported as having an expiration date of September 11, 2023, which has been revised herein. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 139 | $89.10 | $12,384.90 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.04 to $89.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,044 | $88.09 | $268,145.96 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.02 to $88.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,730 | $87.40 | $151,202.00 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,183 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.98 to $87.95. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,613 | $86.38 | $139,330.94 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $86.73. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,673 | $85.19 | $142,522.87 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,526 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.91 to $85.43. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,801 | $84.33 | $151,878.33 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,199 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.88 to $84.77. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $1.14 | $11,400.00 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · derivative · entry 12 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,187 Underlying: Common Stock · 10,000 shares Expires 2023-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 645 | $78.00 | $50,310.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 11 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.17. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,558 | $77.29 | $197,707.82 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.82 to $77.77. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,797 | $75.63 | $514,057.11 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,203 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.29 to $76.23. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 23:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $1.14 | $11,400.00 |
DisclosureSEC source: 0001104659-20-012076 · a4.xml · nonDerivative · entry 8 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073836 · a4.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-12-16 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001104659-19-065436 · a4.xml · derivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,390 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,390 | $63.15 | $403,528.50 |
DisclosureSEC source: 0001104659-19-065436 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 6,390 | $1.47 | $9,393.30 |
DisclosureSEC source: 0001104659-19-065436 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $1.47 Strike: $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,390 Underlying: Common Stock · 5,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 29, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,002 | $60.22 | $180,780.44 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.82 to $60.60. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,998 | $59.48 | $118,841.04 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,902 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.81 to $59.77. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,000 | $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $1.47 Strike: $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,390 Underlying: Common Stock · 5,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 28, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,000 | $58.43 | $292,150.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.92. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,000 | $1.47 | $7,350.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,300 | $1.47 Strike: $1.47 | $13,671.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · derivative · entry 8 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,390 Underlying: Common Stock · 9,300 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 25, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 9,300 | $58.01 | $539,493.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.04. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2019 Filed Oct 29, 2019 23:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 9,300 | $1.47 | $13,671.00 |
DisclosureSEC source: 0001104659-19-057319 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 700 | $1.47 Strike: $1.47 | $1,029.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · derivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,690 Underlying: Common Stock · 700 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $58.30 | $40,810.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.23 to $58.32. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 22:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 700 | $1.47 | $1,029.00 |
DisclosureSEC source: 0001104659-19-053429 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $1.47 Strike: $1.47 | $14,700.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · derivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,390 Underlying: Common Stock · 10,000 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $63.01 | $31,505.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,582 | $62.04 | $160,187.28 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.01 to $62.46. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,918 | $61.36 | $424,488.48 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.01 to $61.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 10,000 | $1.47 | $14,700.00 |
DisclosureSEC source: 0001104659-19-050284 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2019 Filed Mar 6, 2020 23:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $67.63 | $0.00 |
DisclosureSEC source: 0001104659-20-030294 · a4.xml · derivative · entry 10 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-07-31 F8 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 22 | $56.75 | $1,248.50 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 43 | $55.67 | $2,393.81 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 922 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 686 | $54.53 | $37,407.58 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.22 to $55.19. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,249 | $53.76 | $120,906.24 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.20 to $54.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,520 | $56.31 | $198,211.20 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.06 to $57.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,480 | $55.66 | $193,696.80 |
DisclosureSEC source: 0001104659-19-034035 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.06 to $56.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:52 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,400 | $50.01 | $170,034.00 |
DisclosureSEC source: 0001104659-19-026852 · a4.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2019 Filed May 3, 2019 20:52 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,637 | $50.03 | $81,899.11 |
DisclosureSEC source: 0001104659-19-026852 · a4.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:52 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,037 | $50.16 | $252,655.92 |
DisclosureSEC source: 0001104659-19-026852 · a4.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Senior VP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,937 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.